-
Article
Open AccessPI-QUAL version 2: an update of a standardised scoring system for the assessment of image quality of prostate MRI
Multiparametric MRI is the optimal primary investigation when prostate cancer is suspected, and its ability to rule in and rule out clinically significant disease relies on high-quality anatomical and function...
-
Article
Open AccessESR Essentials: using the right scoring system in prostate MRI—practice recommendations by ESUR
MRI has gained prominence in the diagnostic workup of prostate cancer (PCa) patients, with the Prostate Imaging Reporting and Data System (PI-RADS) being widely used for cancer detection. Beyond PI-RADS, other...
-
Article
Active surveillance of prostate cancer: MRI and beyond
-
Article
Open AccessPromoting the use of the PI-QUAL score for prostate MRI quality: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
The Prostate Imaging Quality (PI-QUAL) score is a new metric to evaluate the diagnostic quality of multiparametric magnetic resonance imaging (MRI) of the prostate. This study assesses the impact of an interve...
-
Article
Open AccessPromoting the use of the PRECISE score for prostate MRI during active surveillance: results from the ESOR Nicholas Gourtsoyiannis teaching fellowship
The PRECISE criteria for serial multiparametric magnetic resonance imaging (MRI) of the prostate during active surveillance recommend the use of a dedicated scoring system (PRECISE score) to assess the likelih...
-
Article
Open AccessInter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
The Prostate Imaging Quality (PI-QUAL) score assesses the quality of multiparametric MRI (mpMRI). A score of 1 means all sequences are below the minimum standard of diagnostic quality, 3 implies that the scan ...
-
Article
Open AccessMultiparametric prostate MRI quality assessment using a semi-automated PI-QUAL software program
The technical requirements for the acquisition of multiparametric magnetic resonance imaging (mpMRI) of the prostate have been clearly outlined in the Prostate Imaging Reporting and Data System (PI-RADS) guide...
-
Article
Open AccessUnderstanding PI-QUAL for prostate MRI quality: a practical primer for radiologists
Prostate magnetic resonance imaging (MRI) of high diagnostic quality is a key determinant for either detection or exclusion of prostate cancer. Adequate high spatial resolution on T2-weighted imaging, good dif...
-
Article
Open AccessStandardisation of prostate multiparametric MRI across a hospital network: a London experience
National guidelines recommend prostate multiparametric (mp) MRI in men with suspected prostate cancer before biopsy. In this study, we explore prostate mpMRI protocols across 14 London hospitals and determine ...
-
Article
Open AccessNatural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
The PRECISE recommendations for magnetic resonance imaging (MRI) in patients on active surveillance (AS) for prostate cancer (PCa) include repeated measurement of each lesion, and attribution of a PRECISE radi...
-
Article
Open AccessESUR/ESUI consensus statements on multi-parametric MRI for the detection of clinically significant prostate cancer: quality requirements for image acquisition, interpretation and radiologists’ training
This study aims to define consensus-based criteria for acquiring and reporting prostate MRI and establishing prerequisites for image quality.
-
Article
Open AccessInterobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
We aimed to determine the interobserver reproducibility of the Prostate Cancer Radiological Estimation of Change in Sequential Evaluation (PRECISE) criteria for magnetic resonance imaging in patients on active...
-
Article
Correction to: Machine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists
The original version of this article, published on 11 June 2019, unfortunately contained a mistake. The following correction has therefore been made in the original: In section “Multiparametric MRI review,” th...
-
Article
Open AccessGastric cancer and image-derived quantitative parameters: Part 2—a critical review of DCE-MRI and 18F-FDG PET/CT findings
There is yet no consensus on the application of functional imaging and qualitative image interpretation in the management of gastric cancer. In this second part, we will discuss the role of image-derived quant...
-
Article
Open AccessMachine learning classifiers can predict Gleason pattern 4 prostate cancer with greater accuracy than experienced radiologists
The purpose of this study was: To test whether machine learning classifiers for transition zone (TZ) and peripheral zone (PZ) can correctly classify prostate tumors into those with/without a Gleason 4 componen...
-
Article
Open AccessMulti-parametric MRI zone-specific diagnostic model performance compared with experienced radiologists for detection of prostate cancer
Compare the performance of zone-specific multi-parametric-MRI (mp-MRI) diagnostic models in prostate cancer detection with experienced radiologists.
-
Article
Open AccessGastric cancer and imaging biomarkers: Part 1 – a critical review of DW-MRI and CE-MDCT findings
The current standard of care for gastric cancer imaging includes heterogeneity in image acquisition techniques and qualitative image interpretation. In addition to qualitative assessment, several imaging techn...
-
Article
Open AccessAn update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines
The aim of the current report is to provide an update in the imaging interpretation of prostate cancer on multiparametric magnetic resonance imaging (mpMRI), with a special focus on how to discriminate patholo...
-
Article
Open AccessMRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
To investigate changes in the Apparent Diffusion Coefficient (ADC) using diffusion-weighted imaging (DWI) in men on active surveillance for prostate cancer taking dutasteride 0.5 mg or placebo.